1. Highlights From ATS 2013: An Update on Advances in COPD

2. Goals

3. Reports on the Long-Acting Muscarinic Antagonist Aclidinium

4. Beier et al Results

5. Beeh et al Report

6. Beeh et al Findings

7. Combination Inhaled Corticosteroid and LABA Therapy

8. Dransfield et al Findings

9. Abstracts From a Long-Term Safety Study of the Nebulized LABA Arformoterol

10. Donohue et al Findings

11. Donohue et al Findings (cont)

12. Make et al: Results of Evaluation of Lung Function

13. Hanania et al: Incidence of Adverse Events

14. Hanania et al Findings

15. Mahler et al Study

16. Mahler et al Findings

17. Retrospective Study Comparing Nebulized LABA With Nebulized SABA

18. Yeaw et al

19. Data on Emerging Therapies

20. Wedzicha et al Findingsa

21. Data on Emerging Therapies: Umeclidinium

22. Challenges and Conclusions

23. Challenges and Conclusions (cont)

24. Abbreviations

25. References

26. References (cont)

27. References (cont)